---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-054501"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T06:40:01.276021+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Onconetix granted Nasdaq continued listing; completes reverse stock split to meet bid price rule

## Summary
- Nasdaq Hearings Panel granted continued listing on June 11, 2025, subject to compliance by June 30, 2025.
- Company met periodic filing rule by filing Q1 10-Q on June 12, 2025.
- Completed 1-for-85 reverse stock split on June 13, 2025 to address bid price requirement.
- Expects to demonstrate compliance with bid price rule by close of business June 27, 2025.
- Hearing held May 27, 2025; company's request for continued listing was granted.

## SEC filing metadata
- accession: 0001213900-25-054501
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/0001213900-25-054501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/ea0245818-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-054501
- JSON: https://secwatch.observer/filing/0001213900-25-054501.json
- Plain text: https://secwatch.observer/filing/0001213900-25-054501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.